Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

[Sinusoidal obstruction syndrome caused by sorafenib administration after hepatectomy for liver cancer: a case report].

Yi PP, Sha XP, Huang Y, Liu GZ, Quan J.

Zhonghua Gan Zang Bing Za Zhi. 2016 Jun;24(6):458-60. doi: 10.3760/cma.j.issn.1007-3418.2016.06.014. Chinese. No abstract available.

PMID:
27465953
2.

Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.

Nakamura K, Hatano E, Narita M, Miyagawa-Hayashino A, Koyama Y, Nagata H, Iwaisako K, Taura K, Uemoto S.

J Hepatol. 2012 Nov;57(5):1037-43. doi: 10.1016/j.jhep.2012.07.004. Epub 2012 Jul 11.

3.

Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome.

Schiffer E, Frossard JL, Rubbia-Brandt L, Mentha G, Pastor CM.

J Surg Oncol. 2009 Jun 1;99(7):439-46. doi: 10.1002/jso.21276.

PMID:
19353590
4.

Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.

Nakamura K, Hatano E, Miyagawa-Hayashino A, Okuno M, Koyama Y, Narita M, Seo S, Taura K, Uemoto S.

Liver Int. 2014 Nov;34(10):1473-87. doi: 10.1111/liv.12420. Epub 2014 Feb 6.

PMID:
24498917
5.

Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.

Martins J, Alexandrino H, Oliveira R, Cipriano MA, Falcão D, Ferreira L, Martins R, Serôdio M, Martins M, Tralhão JG, Prado e Castro L, Castro E Sousa F.

Eur J Surg Oncol. 2016 May;42(5):713-21. doi: 10.1016/j.ejso.2016.02.017. Epub 2016 Feb 24.

PMID:
26972374
6.

Ultrastructural study of the remnant liver after extensive hepatectomy in dogs; especially morphological alterations of sinusoidal endothelial cells.

Kuroda H, Kawarada Y, Das BC, Iwata M, Isaji S.

Hepatogastroenterology. 2000 Mar-Apr;47(32):450-4.

PMID:
10791211
7.

Recovery of liver perfusion after focal outflow obstruction and liver resection.

Dirsch O, Madrahimov N, Chaudri N, Deng M, Madrahimova F, Schenk A, Dahmen U.

Transplantation. 2008 Mar 15;85(5):748-56. doi: 10.1097/TP.0b013e31816631f9. Erratum in: Transplantation. 2008 Jun 27;85(12):1866.

PMID:
18337670
8.

Oxaliplatin-induced liver injury mimicking metastatic tumor on images: a case report.

Uchino K, Fujisawa M, Watanabe T, Endo Y, Nobuhisa T, Matsumoto Y, Kai K, Sato S, Notohara K, Matsukawa A.

Jpn J Clin Oncol. 2013 Oct;43(10):1034-8. doi: 10.1093/jjco/hyt113. Epub 2013 Aug 19.

PMID:
23958518
9.

Effect of sorafenib on murine liver regeneration.

Hora C, Romanque P, Dufour JF.

Hepatology. 2011 Feb;53(2):577-86. doi: 10.1002/hep.24037. Epub 2011 Jan 4.

PMID:
21274878
10.

Regorafenib suppresses sinusoidal obstruction syndrome in rats.

Okuno M, Hatano E, Nakamura K, Miyagawa-Hayashino A, Kasai Y, Nishio T, Seo S, Taura K, Uemoto S.

J Surg Res. 2015 Feb;193(2):693-703. doi: 10.1016/j.jss.2014.08.052. Epub 2014 Sep 6.

11.

Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.

Narita M, Oussoultzoglou E, Chenard MP, Fuchshuber P, Rather M, Rosso E, Addeo P, Jaeck D, Bachellier P.

Ann Surg Oncol. 2012 Jul;19(7):2230-7. doi: 10.1245/s10434-011-2112-6. Epub 2012 Mar 9.

PMID:
22402811
12.

Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.

Tamandl D, Klinger M, Eipeldauer S, Herberger B, Kaczirek K, Gruenberger B, Gruenberger T.

Ann Surg Oncol. 2011 Feb;18(2):421-30. doi: 10.1245/s10434-010-1317-4. Epub 2010 Sep 16.

PMID:
20844968
13.

Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.

Soubrane O, Brouquet A, Zalinski S, Terris B, Brézault C, Mallet V, Goldwasser F, Scatton O.

Ann Surg. 2010 Mar;251(3):454-60. doi: 10.1097/SLA.0b013e3181c79403.

PMID:
20160638
14.

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B.

Ann Oncol. 2004 Mar;15(3):460-6.

PMID:
14998849
15.

[A case of advanced hepatocellular carcinoma successfully treated by liver resection after complete response induced by sorafenib administration].

Kim Y, Hosoda Y, Kakita N, Yamada Y, Yamasaki M, Nishino M, Okano M, Nagai K, Yasui M, Tsujinaka T.

Gan To Kagaku Ryoho. 2014 Nov;41(12):2124-6. Japanese.

PMID:
25731444
16.

Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition.

Deleve LD, Wang X, Tsai J, Kanel G, Strasberg S, Tokes ZA.

Gastroenterology. 2003 Sep;125(3):882-90.

PMID:
12949732
17.

[Three cases of recurrent hepatocellular carcinoma treated with laparoscopic hepatectomy after oral administration of sorafenib].

Komatsu H, Tsukamoto T, Kodai S, Kanazawa A, Shimizu S, Yamazoe S, Ohira G, Nakajima T, Nakai T, Kawasaki Y, Kioka K.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1672-4. Japanese.

PMID:
24393884
19.

Safety of liver resection for hepatocellular carcinoma after sorafenib therapy: a multicenter case-matched study.

Barbier L, Fuks D, Pessaux P, Muscari F, Le Treut YP, Faivre S, Belghiti J.

Ann Surg Oncol. 2013 Oct;20(11):3603-9. doi: 10.1245/s10434-013-3029-z. Epub 2013 May 29.

PMID:
23715965
20.

Sorafenib prolongs liver regeneration after hepatic resection in rats.

Mollbrink A, Augsten M, Hultcrantz R, Eriksson LC, Stål P.

J Surg Res. 2013 Oct;184(2):847-54. doi: 10.1016/j.jss.2013.04.062. Epub 2013 May 18.

PMID:
23726434

Supplemental Content

Support Center